Y

YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558

Watchlist Manager
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Watchlist
Price: 10.02 HKD -3.84% Market Closed
Updated: May 24, 2024

YiChang HEC ChangJiang Pharmaceutical Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

YiChang HEC ChangJiang Pharmaceutical Co Ltd
Research & Development Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Y
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Research & Development
-¥192.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Research & Development
-¥2.1B
CAGR 3-Years
-19%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Research & Development
-¥228.3m
CAGR 3-Years
-37%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Research & Development
-¥5B
CAGR 3-Years
3%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Research & Development
-¥329.2m
CAGR 3-Years
-21%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Research & Development
-¥712.5m
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Research & Development?
Research & Development
-192.3m CNY

Based on the financial report for Dec 31, 2023, YiChang HEC ChangJiang Pharmaceutical Co Ltd's Research & Development amounts to -192.3m CNY.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-48%

Over the last year, the Research & Development growth was -48%.